HBK Investments’s GoHealth GOCO Stock Holding History

HBK Investments’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,000	Closed	-$3.91M	–	718
2020 Q3	$3.91M	Buy	+20,000	New	+$4.82M	0.03%	274

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

HBK Investments's GOCO Position: Q4 2020 in Review

HBK Investments sold out of GoHealth (GOCO) in Q4 2020, closing a stake of 20,000 shares — an estimated $3.91M sold.

HBK Investments first reported a position in GOCO in Q3 2020 and held it in 1 quarter. The position peaked at $3.91M in Q3 2020. 99 funds tracked by Wall St. Rank hold GOCO as of Q4 2020.

HBK Investments reported no remaining GoHealth position as of Q4 2020 after selling out during the quarter.
HBK Investments sold 20,000 GoHealth shares in Q4 2020, an estimated $3.91M.
HBK Investments first reported a position in GoHealth in Q3 2020 and held it in 1 quarter.
HBK Investments's GoHealth position peaked at $3.91M in Q3 2020.
99 funds tracked by Wall St. Rank held GoHealth as of Q4 2020.

Based on HBK Investments's 13F filing for Q4 2020, filed 16 Feb 2021.